Basic Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Jun 28, 2017; 23(24): 4390-4398
Published online Jun 28, 2017. doi: 10.3748/wjg.v23.i24.4390
Figure 2
Figure 2 Proliferation assays of gastric cancer cell strains treated with purified gp96-peptide complexes. MTS assays were performed for: A: KATOIII source GP96-gastric cancer (GC) antigen peptide complexes (gp96K-Pep) vs KATOIII source antigen peptide (K-Pep); B: MKN-28 source GP96-GC antigen peptide complexes (gp96M-Pep) vs MKN-28 source antigen peptide (M-Pep); C: SGC-7901 source gp96-GC antigen peptide complexes (p96S-Pep) vs SGC-7901 source antigen peptide (S-Pep). aP < 0.05.